Chinese lingerie brand NEIWAI raises $100m in Series D led by Carlyle
July 16, 2021
PE giant Carlyle has led a $100 million Series D round in NEIWAI, an emerging lingerie brand in China, according to an announcement.
The round has attracted the company’s existing investors namely, Singapore’s Vertex Ventures, and Chinese investment firm Qiming Venture Partners.
Investment bank Investarget facilitated the transaction.
Qiming had earlier infused 150 million ($23 million) in NEIWAI’s Series C round in 2019. Prior to that, in 2017, Vertex along with a slew of Chinese investors such as ZhenFund and Qifu had pumped in 70 million yuan ($11 million) in the company’s Series B round.
China Digest: Dearer nets $65m; Temasek backs Abiochem
Dearer nets $65m in Series B
Shanghai-headquartered contact lens manufacturer Dearer has raised 420 million yuan ($65 million) in a Series B round of financing.
State-backed alternative asset manager CITIC Private Equity Funds Management (CPE), Legend Holdings’ investment arm Legend Capital and BioTrack Capital joined the round. Insight Capital made a follow-on investment in the round.
The company will use the proceeds for R&D and mass production of coloured contact lenses, the company said in a statement.
Its early-stage investors include Orient Securities, Borchid Capital, FOF Capital and eyecare service provider Eyebright.
Temasek invests in Abiochem
10 Stocks that Pay Dividends Monthly
Investing in stocks that pay dividends monthly or regularly is an excellent strategy for investors who want consistent returns. Many dividend stocks have regular payouts every quarter, but this might not be an ideal situation for investors who have regular bills. If you are an investor who wants to have some extra cash flow every month, then stocks that pay dividends monthly should be on your radar. Finding companies that have monthly dividends payout is not exactly a walk in the park. Investors should consider company fundamentals and other important information about the company’s performance before investing in a dividend stock. Not all dividend stocks are healthy. Investors, therefore, need to put in some research to determine which stocks that best suit their needs.